Inventor · disambiguated record
Wilson Edwards
Also filed as: EDWARDS WILSON · EDWARDS WILSON B
15 granted patents·12 pending applications·33 citations·filing 2014–2025
91Inventor score
Files withJANSSEN PHARMACEUTICA NV18JANSSEN BIOTECH INC5JANSSEN SCIENCES IRELAND UNLIMITED CO2UNIV PITTSBURGH1UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION1
Top patents by PatentIndex Score
27 records- 0197US11767354B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 26, 2023·3 cites·23 claims
- 0296US11236155B2Antibodies to pyroglutamate amyloid-β and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 1, 2022·4 cites·23 claims
- 0396US10428134B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 1, 2019·7 cites·21 claims
- 0495US11591379B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 28, 2023·3 cites·20 claims
- 0594US10968265B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·4 cites·24 claims
- 0694US10787495B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 29, 2020·3 cites·20 claims
- 0794US10640544B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 5, 2020·4 cites·28 claims
- 0893US11401315B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 2, 2022·2 cites·24 claims
- 0993US10858413B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 8, 2020·3 cites·17 claims
- 1092US2025026803A1Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1186US2023365644A1Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1280US2025320286A1Antibodies to pyroglutamate amyloid-b and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2025·Application pending·0 cites
- 1378US12134636B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 5, 2024·0 cites·35 claims
- 1477US2024117000A1Glucagon like peptide 1 (glp-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2023·Application pending·0 cites
- 1571US2022106387A1Antibodies to pyroglutamate amyloid-b and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1665US11780900B2Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Oct 10, 2023·0 cites·27 claims
- 1763US10875902B2Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Dec 29, 2020·0 cites·30 claims
- 1861US2025136672A1Multispecific antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1961US2025188181A1Multispecific antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2061US2025129144A1Multispecific antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2160US2025179196A1Materials and methods of making or using il-23r binding proteinsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2256US10179808B2Kv1.3 antagonists and methods of useJANSSEN BIOTECH INC·Filed 2014·Granted Jan 15, 2019·0 cites·12 claims
- 2355US12162951B2Anti-idiotypic antibodies against anti-KLK2 antibodiesJANSSEN BIOTECH INC·Filed 2021·Granted Dec 10, 2024·0 cites·29 claims
- 2455US2022296737A1Immunopet and immunospect imaging to identify cytotoxic t cell activityUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 2551US12030937B2Anti-idiotypic antibodies against anti-GPRC5D antibodiesJANSSEN BIOTECH INC·Filed 2021·Granted Jul 9, 2024·0 cites·30 claims
- 2651US2019062383A1Kv1.3 Antagonists and Methods of UseJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 2748US2016185735A1Fatty acid analogs and their useUNIV PITTSBURGH·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wilson Edwards files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →